APA (7th ed.) Citation

Barbastefano, J., Garcia, J. A., Elson, P., Wood, L. S., Lane, B. R., Dreicer, R., . . . Rini, B. I. (2010). Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. BJU International, 106(9), 1266. https://doi.org/10.1111/j.1464-410X.2010.09323.x

Chicago Style (17th ed.) Citation

Barbastefano, Juan, Jorge A. Garcia, Paul Elson, Laura S. Wood, Brian R. Lane, Robert Dreicer, Steven C. Campbell, and Brian I. Rini. "Association of Percentage of Tumour Burden Removed with Debulking Nephrectomy and Progression-free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy." BJU International 106, no. 9 (2010): 1266. https://doi.org/10.1111/j.1464-410X.2010.09323.x.

MLA (9th ed.) Citation

Barbastefano, Juan, et al. "Association of Percentage of Tumour Burden Removed with Debulking Nephrectomy and Progression-free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy." BJU International, vol. 106, no. 9, 2010, p. 1266, https://doi.org/10.1111/j.1464-410X.2010.09323.x.